NYSCF Scientific Discovery Biobank : NYSCF Scientific Discovery Biobank
Researchers at the New York Stem Cell Foundation (NYSCF) Research Institute study diverse diseases, conditions, and traits by creating stem cells from biological samples. These "pluripotent" stem cells can become any cell in the human body, including cells that may be difficult, invasive, or impossible to obtain directly.Additionally, researchers perform genetic testing to learn more about DNA, a material in most cells that contains instructions for the body's development and functions (such as traits like eye color and risk of certain diseases). A piece of DNA that determines the specific role of a cell is called a "gene." If the instructions in a gene are abnormal, this can lead to disease.Participation in the study involves: (1) completion of health questionnaires, (2) providing a skin and/or blood sample from which stem cells may be created, (3) collection of a saliva sample for genetic analysis, and (4) possible future followup to provide additional information or learn about other research studies.This study is not a clinical trial..
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
ClinicalTrials.gov - (2024) vom: 22. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: Link to the current ClinicalTrials.gov record., First posted: January 12, 2024, Last downloaded: ClinicalTrials.gov processed this data on March 27, 2024, Last updated: March 27, 2024 |
|---|
| Study ID: |
NCT06203106 |
|---|---|
| Veröffentlichungen zur Studie: |
|
| fisyears: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
CTG00013001X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG00013001X | ||
| 003 | DE-627 | ||
| 005 | 20240327010340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)CTG00013001X | ||
| 035 | |a (UBBS_Klinische_Studien)NCT06203106 | ||
| 035 | |a (UBBS_Klinische_Studien)10-010 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a NYSCF Scientific Discovery Biobank |b NYSCF Scientific Discovery Biobank |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: Link to the current ClinicalTrials.gov record., First posted: January 12, 2024, Last downloaded: ClinicalTrials.gov processed this data on March 27, 2024, Last updated: March 27, 2024 | ||
| 520 | |a Researchers at the New York Stem Cell Foundation (NYSCF) Research Institute study diverse diseases, conditions, and traits by creating stem cells from biological samples. These "pluripotent" stem cells can become any cell in the human body, including cells that may be difficult, invasive, or impossible to obtain directly.Additionally, researchers perform genetic testing to learn more about DNA, a material in most cells that contains instructions for the body's development and functions (such as traits like eye color and risk of certain diseases). A piece of DNA that determines the specific role of a cell is called a "gene." If the instructions in a gene are abnormal, this can lead to disease.Participation in the study involves: (1) completion of health questionnaires, (2) providing a skin and/or blood sample from which stem cells may be created, (3) collection of a saliva sample for genetic analysis, and (4) possible future followup to provide additional information or learn about other research studies.This study is not a clinical trial. | ||
| 650 | 2 | |a Ovarian Neoplasms | |
| 650 | 2 | |a Uterine Cervical Neoplasms | |
| 650 | 2 | |a Vulvar Neoplasms | |
| 650 | 2 | |a Vaginal Neoplasms | |
| 650 | 2 | |a Uterine Neoplasms | |
| 650 | 2 | |a Parkinson Disease | |
| 650 | 2 | |a Multiple Sclerosis | |
| 650 | 2 | |a Alzheimer Disease | |
| 650 | 2 | |a Dementia | |
| 650 | 2 | |a Motor Neuron Disease | |
| 650 | 2 | |a Amyotrophic Lateral Sclerosis | |
| 650 | 2 | |a Huntington Disease | |
| 650 | 2 | |a Multiple System Atrophy | |
| 650 | 2 | |a Shy-Drager Syndrome | |
| 650 | 2 | |a Frontotemporal Dementia | |
| 650 | 2 | |a Aphasia, Primary Progressive | |
| 650 | 2 | |a Pick Disease of the Brain | |
| 650 | 2 | |a Parkinsonian Disorders | |
| 650 | 2 | |a Supranuclear Palsy, Progressive | |
| 650 | 2 | |a Lewy Body Disease | |
| 650 | 2 | |a Neuronal Ceroid-Lipofuscinoses | |
| 650 | 2 | |a Corticobasal Degeneration | |
| 650 | 2 | |a Macular Degeneration | |
| 650 | 2 | |a Diabetes Mellitus | |
| 650 | 2 | |a Diabetes Mellitus, Type 2 | |
| 650 | 2 | |a Diabetes Mellitus, Type 1 | |
| 650 | 2 | |a Sclerosis | |
| 650 | 2 | |a Atrophy | |
| 650 | 2 | |a Late Onset Disorders | |
| 650 | 2 | |a Stress Disorders, Traumatic | |
| 650 | 2 | |a Stress Disorders, Post-Traumatic | |
| 650 | 4 | |a Study Type: Observational | |
| 650 | 4 | |a Recruitment Status: Recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t ClinicalTrials.gov |g (2024) vom: 22. März |
| 773 | 1 | 8 | |g year:2024 |g day:22 |g month:03 |
| 856 | 4 | 0 | |u https://clinicaltrials.gov/show/NCT06203106 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 22 |c 03 | ||